Monthly information regarding the total number of voting rights and total number of shares of the Company as of October 31, 2023
(Article 223-16 of the General Regulations of the Autorité des Marchés Financiers)
Market : NYSE Euronext Paris
ISIN Code: FR 0010417345
| Date | Total number of shares | Total number of voting rights |
| 10/31/2023 | 96,288,553 | Total gross of voting rights: 96,288,553 |
| Total net* of voting rights: 96,084,083 |
* Net total = total number of voting rights attached to shares – shares without voting rights
| Last Trade: | US$10.83 |
| Daily Change: | -0.16 -1.46 |
| Daily Volume: | 2,574 |
| Market Cap: | US$296.310M |
January 08, 2025 | |
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MORE
Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MORE
